Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo

Lymphokine Res. 1989 Fall;8(3):245-50.

Abstract

The LPS induced synthesis of tumor necrosis factor in macrophage cultures, as determined in a fibroblast cytolysis assay was found to be effectively blocked by inhibitors of lipoxygenases. Likewise, the presence of tumor necrosis factor in serum of D-galactosamine sensitized mice after challenge with endotoxin was suppressed by the lipoxygenase inhibitors. Indomethacin, a blocker of cycclooxygenase was neither in vivo nor in vitro effective in the prevention of the endotoxin-induced synthesis of TNF. From LPS-treated macrophages we were able to isolate 13-hydroxylinoleic acid, a lipoxygenase product, which is significantly increased after LPS treatment of the cells, covalently bound to cellular constituents and may, therefore, be possibly involved in the formation of TNF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Female
  • Galactosamine / pharmacology
  • Linoleic Acids / metabolism
  • Lipopolysaccharides / pharmacology
  • Lipoxygenase Inhibitors*
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Mice
  • Tumor Necrosis Factor-alpha / biosynthesis*

Substances

  • Linoleic Acids
  • Lipopolysaccharides
  • Lipoxygenase Inhibitors
  • Tumor Necrosis Factor-alpha
  • 13-hydroxylinoleic acid
  • Galactosamine